BACKGROUND: Meta-analyses suggest that schizophrenia patients with a history of cannabis use have less impaired cognitive functioning compared to patients without cannabis use. AIMS: The objective of this study was to assess the association between recency and frequency of cannabis use and cognitive functioning in at-risk mental state for psychosis (ARMS) and first episode psychosis (FEP) individuals. METHODS: One hundred thirty-six participants completed a cognitive test battery and were assessed for current and past cannabis use. Analyses of covariance models were applied to evaluate the main effects of cannabis use and patient group (ARMS vs. FEP) as well as their interactions on cognitive functioning. RESULTS: No differences were observed in cognitive performance between current, former, and never users, and there were no significant interactions between cannabis use and patient group. Furthermore, within the group of current cannabis users, the frequency of cannabis use was not significantly associated with cognitive functioning. CONCLUSION: The results of the present study do not support the notion that FEP patients and ARMS individuals with a history of cannabis use have less impaired cognitive functioning compared to those without cannabis use.
BACKGROUND: Meta-analyses suggest that schizophreniapatients with a history of cannabis use have less impaired cognitive functioning compared to patients without cannabis use. AIMS: The objective of this study was to assess the association between recency and frequency of cannabis use and cognitive functioning in at-risk mental state for psychosis (ARMS) and first episode psychosis (FEP) individuals. METHODS: One hundred thirty-six participants completed a cognitive test battery and were assessed for current and past cannabis use. Analyses of covariance models were applied to evaluate the main effects of cannabis use and patient group (ARMS vs. FEP) as well as their interactions on cognitive functioning. RESULTS: No differences were observed in cognitive performance between current, former, and never users, and there were no significant interactions between cannabis use and patient group. Furthermore, within the group of current cannabis users, the frequency of cannabis use was not significantly associated with cognitive functioning. CONCLUSION: The results of the present study do not support the notion that FEP patients and ARMS individuals with a history of cannabis use have less impaired cognitive functioning compared to those without cannabis use.
Authors: Nikolaos Koutsouleris; Christos Davatzikos; Ronald Bottlender; Katja Patschurek-Kliche; Johanna Scheuerecker; Petra Decker; Christian Gaser; Hans-Jürgen Möller; Eva M Meisenzahl Journal: Schizophr Bull Date: 2011-05-16 Impact factor: 9.306
Authors: Madeline H Meier; Avshalom Caspi; Antony Ambler; HonaLee Harrington; Renate Houts; Richard S E Keefe; Kay McDonald; Aimee Ward; Richie Poulton; Terrie E Moffitt Journal: Proc Natl Acad Sci U S A Date: 2012-08-27 Impact factor: 11.205
Authors: Warrick J Brewer; Stephen J Wood; Lisa J Phillips; Shona M Francey; Christos Pantelis; Alison R Yung; Barbara Cornblatt; Patrick D McGorry Journal: Schizophr Bull Date: 2006-06-16 Impact factor: 9.306
Authors: Priyanthi B Gjerde; Synne W Steen; Trude S J Vedal; Nils Eiel Steen; Elina J Reponen; Ole A Andreassen; Vidar M Steen; Ingrid Melle Journal: Front Psychiatry Date: 2022-03-29 Impact factor: 4.157
Authors: Laura Egloff; Erich Studerus; Ronan Zimmermann; Ulrike Heitz; Stephanie Menghini-Müller; Sarah Ittig; Katharina Beck; Christina Andreou; Stefan Borgwardt; Anita Riecher-Rössler Journal: PLoS One Date: 2018-05-10 Impact factor: 3.240
Authors: Teresa Sánchez-Gutiérrez; Belén Fernandez-Castilla; Sara Barbeito; Ana González-Pinto; Juan Antonio Becerra-García; Ana Calvo Journal: Eur Psychiatry Date: 2020-01-31 Impact factor: 5.361